BRITTANY MARTIN: Open Payments
NPI 1003546532 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,249 in 99 payments from 14 companies in 2025. Trend: 2023 $781 · 2024 $1,048 · 2025 $2,249
Food & beverage: $1,630Travel & lodging: $612Education: $8
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $936 |
| Axsome Therapeutics, Inc. | 11 | $279 |
| Supernus Pharmaceuticals, Inc. | 25 | $240 |
| ABBVIE INC. | 12 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $181 |
| Lundbeck LLC | 16 | $173 |
| Bausch Health US, LLC | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $21 |
Products named: SPRAVATO, Auvelity, Qelbree, REXULTI, VRAYLAR, CAPLYTA, APLENZIN, FANAPT.
Industry payments across KY — which companies pay providers there.
